Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
RMDA.CA Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: May 26, 2026
Report Source: 2026 1st Quarter Report
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE). Stock Analysis RMDA.CA
Egypt Health Care Micro Cap Report: Tenth of Ramadan Company for Pharmaceuticals Industries & Diagnostic Reagents S.A.E. The company is headquartered in Giza, Giza. The company went IPO on 2019-11-27. The company operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others. The firm owns an extensive product portfolio covering anti-infective, anti-diabetic, respiratory, ophthalmology, gastro-intestinal tract, cardio-vascular, central nervous system, vitamins and analgesics. Additionally, the Company provides contract manufacturing services to a number of local and multinational pharmaceutical companies.
Read More Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA) Chart
Key Statistics of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
EGP5.10Volume
1.95MP/E Ratio (TTM)
33.7752 Week Range
Market Cap
10.16BAvg. Volume
17.51MDividend Yield
1.87%Financial Metrics & Statements of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA)
FAQ's for Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA)
- According to Musaffa’s Shariah screening methodology, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) using these criteria to determine its compliance status.
- Muslim investors may consider investing in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.